Core Viewpoint - The U.S. plans to impose tariffs on imported pharmaceuticals, starting with a small rate and increasing it significantly over the next year to encourage domestic production [1] Group 1: Pharmaceutical Industry - President Trump announced that tariffs on imported drugs will initially be low but will rise to 150% within a year, and potentially to 250% thereafter [1] - The specific initial tariff rate for pharmaceuticals has not been disclosed [1] Group 2: Semiconductor Industry - Trump indicated that he will announce tariffs on semiconductors and chips in about a week, although details were not provided [1]

Group 1 - The core point of the article is that President Trump has announced a potential 35% tariff on the European Union if they do not fulfill their obligations [1] Group 2 - The announcement indicates a significant escalation in trade tensions between the United States and the European Union [1] - This move could have substantial implications for industries reliant on transatlantic trade [1] - The potential tariff rate of 35% is notably high and could impact pricing and competitiveness of goods imported from the EU [1]

白宫：对印度征收25%的关税。 ...

白宫：将对瑞士商品征收39%的关税。 ...

白宫：对孟加拉国征收20%的关税。 ...

白宫：对泰国征收19%的关税；对南非征收30%关税；对土耳其征收15%的关税；委内瑞拉关税税率为 15%。 ...

白宫：将对马来西亚商品征收19%关税；对越南征收20%关税。 ...

白宫：对以色列征收15%关税。 ...

美国将对柬埔寨商品征收19%的关税。 ...

Group 1 - The core point of the article is that Trump has agreed to extend the trade agreement with Mexico for an additional 90 days, during which trade issues will be discussed [1] - Mexico will continue to pay a 25% tariff as part of the ongoing negotiations [1]